JAMA Otolaryngology–Head & Neck Surgery —The Year in Review, 2025 - Scorecard - MDSpire

JAMA Otolaryngology–Head & Neck Surgery —The Year in Review, 2025

  • By

  • Jay F. Piccirillo

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Annual Review of JAMA Otolaryngology–Head & Neck Surgery: Highlights from 2025

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationChildren with DFNB9, patients with locally advanced head and neck squamous cell carcinoma, patients with thyroid diseases (specify types).
Care Setting

Key Highlights

  • AI applications

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • D
      • e
      • t
      • a
      • i
      • l
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • t
      • o
      • o
      • l
      • s
      • o
      • r
      • m
      • e
      • t
      • h
      • o
      • d
      • o
      • l
      • o
      • g
      • i
      • e
      • s
      • f
      • o
      • r
      • p
      • r
      • e
      • d
      • i
      • c
      • t
      • i
      • n
      • g
      • t
      • r
      • e
      • a
      • t
      • m
      • e
      • n
      • t
      • r
      • e
      • s
      • p
      • o
      • n
      • s
      • e
      • .

      Risks

        Patient & Prescribing Data

        Patients with hereditary hearing loss, head and neck cancer, thyroid disease

        Gene therapy and immune checkpoint inhibitors are emerging treatment options.

        Clinical Best Practices

        • thermal ablation

        Related Resources & Content

        Original Source(s)

        Related Content